These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 21704782

  • 41. Modification of altered ankle motor control after stroke using focal application of botulinum toxin type A.
    Tang SF, Hong JP, McKay WB, Tang CW, Wu PH, Chu NK.
    Clin Neurol Neurosurg; 2012 Jun; 114(5):498-501. PubMed ID: 22480620
    [Abstract] [Full Text] [Related]

  • 42. Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia.
    Pelletier F, Parratte B, Penz S, Moreno JP, Aubin F, Humbert P.
    Br J Dermatol; 2011 Mar; 164(3):617-22. PubMed ID: 21275944
    [Abstract] [Full Text] [Related]

  • 43. Long term effects of intra-articular botulinum toxin A for refractory joint pain.
    Mahowald ML, Singh JA, Dykstra D.
    Neurotox Res; 2006 Apr; 9(2-3):179-88. PubMed ID: 16785116
    [Abstract] [Full Text] [Related]

  • 44. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
    Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M.
    Disabil Rehabil; 2010 Apr; 32(17):1414-8. PubMed ID: 20156046
    [Abstract] [Full Text] [Related]

  • 45. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
    Chankrachang S, Arayawichanont A, Poungvarin N, Nidhinandana S, Boonkongchuen P, Towanabut S, Sithinamsuwan P, Kongsaengdao S.
    Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
    [Abstract] [Full Text] [Related]

  • 46. Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review.
    Kharkar S, Ambady P, Venkatesh Y, Schwartzman RJ.
    Pain Physician; 2011 Jan; 14(5):419-24. PubMed ID: 21927045
    [Abstract] [Full Text] [Related]

  • 47. A Novel Use of Regional Anesthesia for Spastic Hemiplegia Evaluation and Treatment: A Case Report.
    Nagpal AS, Eckmann MS, Benfield J.
    PM R; 2016 Feb; 8(2):180-2. PubMed ID: 26253247
    [Abstract] [Full Text] [Related]

  • 48. Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.
    Beer KR, Wilson F.
    Dermatol Surg; 2011 Jun; 37(6):870-2. PubMed ID: 21605254
    [No Abstract] [Full Text] [Related]

  • 49. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
    Gottsch HP, Yang CC, Berger RE.
    Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
    [Abstract] [Full Text] [Related]

  • 50. Botulinum toxin injections for shoulder and upper limb pain: a narrative review.
    Chang KV, Chiu YH, Wu WT, Hsu PC, Özçakar L.
    Pain Manag; 2020 Nov; 10(6):411-420. PubMed ID: 33073703
    [Abstract] [Full Text] [Related]

  • 51. The effects of hyaluronic acid on hemiplegic shoulder injury and pain in patients with subacute stroke: A randomized controlled pilot study.
    Huang YC, Leong CP, Wang L, Chen MJ, Chuang CY, Liaw MY, Wang LY.
    Medicine (Baltimore); 2016 Dec; 95(49):e5547. PubMed ID: 27930553
    [Abstract] [Full Text] [Related]

  • 52. Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.
    Mouttalib S, Khan S, Castel-Lacanal E, Guillotreau J, De Boissezon X, Malavaud B, Marque P, Rischmann P, Gamé X.
    BJU Int; 2010 Dec; 106(11):1677-80. PubMed ID: 20590550
    [Abstract] [Full Text] [Related]

  • 53. Botulinum toxin for lower lid entropion correction.
    Deka A, Saikia SP.
    Orbit; 2011 Jan; 30(1):40-2. PubMed ID: 21281080
    [Abstract] [Full Text] [Related]

  • 54. The long-term effects of hyaluronic acid on hemiplegic shoulder pain and injury in stroke patients: A randomized controlled study.
    Huang YC, Leong CP, Tso HH, Chen MJ, Liaw MY, Hsieh HC, Wang LY, Hsu CH.
    Medicine (Baltimore); 2018 Aug; 97(35):e12078. PubMed ID: 30170424
    [Abstract] [Full Text] [Related]

  • 55. Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
    Lowe PL, Lowe NJ.
    Dermatol Surg; 2014 Dec; 40(12):1328-33. PubMed ID: 25350125
    [Abstract] [Full Text] [Related]

  • 56. Efficacy of Botulinum Toxin A Treatment for Pes Varus during Gait.
    Tanikawa H, Kagaya H, Saitoh E, Ozaki K, Hirano S, Itoh N, Yamada J, Kanada Y.
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2416-22. PubMed ID: 26232889
    [Abstract] [Full Text] [Related]

  • 57. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
    Ahmed K, Oas KH, Mack KJ, Garza I.
    Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
    [Abstract] [Full Text] [Related]

  • 58. Enduring efficacy of Botulinum toxin type A injection for refractory anterior knee pain.
    Silbert BI, Singer BJ, Silbert PL, Gibbons JT, Singer KP.
    Disabil Rehabil; 2012 Nov; 34(1):62-8. PubMed ID: 21936736
    [Abstract] [Full Text] [Related]

  • 59. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles.
    Thomson AJ, Jarvis SK, Lenart M, Abbott JA, Vancaillie TG.
    BJOG; 2005 Feb; 112(2):247-9. PubMed ID: 15663593
    [No Abstract] [Full Text] [Related]

  • 60. Botulinum toxin type A in refractory chronic migraine: an open-label trial.
    Menezes C, Rodrigues B, Magalhães E, Melo A.
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):596-8. PubMed ID: 17876397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.